1.Non-steroidal anti-inflammatory drug-induced enteropathy.
Sung Jae SHIN ; Choong Kyun NOH ; Sun Gyo LIM ; Kee Myung LEE ; Kwang Jae LEE
Intestinal Research 2017;15(4):446-455
Non-steroidal anti-inflammatory drugs (NSAIDs) are well known to be associated with serious upper gastrointestinal complications, such as peptic ulcer, bleeding, perforation, and obstruction. Recently, attention has been mainly focused on the small bowel injuries caused by NSAIDs, and new endoscopic techniques such as capsule endoscopy and double balloon endoscopy can help in detecting such injuries. This article reviewed the epidemiology, pathogenesis, clinical manifestations, diagnosis, and treatment of small bowel injuries caused by NSAIDs. Small bowel injures by NSAIDs might occur with a similar frequency and extent as those observed in the upper gastrointestinal tract. The pathogenesis of NSAID-induced enteropathy is complex and not clearly understood. The various lesions observed in the small bowel, including petechiae, reddened folds, loss of villi, erosions, and ulcers can be detected by capsule endoscopy. A drug that could prevent or treat NSAID-induced enteropathy has not yet been developed. Therefore, further investigations should be performed to elucidate the pathogenesis of such enteropathy and develop suitable preventive and treatment strategies.
Anti-Inflammatory Agents, Non-Steroidal
;
Capsule Endoscopy
;
Diagnosis
;
Endoscopy
;
Epidemiology
;
Hemorrhage
;
Peptic Ulcer
;
Purpura
;
Ulcer
;
Upper Gastrointestinal Tract
2.Structural and Physio-chemical Properties of Helicobacter pylori.
Hanyang Medical Reviews 2007;27(3):4-27
In 1983 when Marshall and Warren first reported the gastric pathogen H. pylori, microbiologists and gastroenterologists would not have predicted that this bacterium would have been shown to be one of the most common bacterial infection in human and the ethiologic agent of the majority of gastrodoudenal disorders. Although there are many documents of the presence of a gastric pathogen in the stomach of human, few have paid attention to it due to difficulty in sampling and bias for asceptic conditions of gastric juice. Now H. pylori is recognized as an etiological pathogen of gastroduodenal disorders including chronic gastritis, peptic ulcer, and gastric cancers. H. pylori colonizes, restricted to gastric mucosa resulting in pathogenic events for inflammatory responses. Bacterial components of H. pylori could contribute to its adherence, adaptation, and colonization to/in gastric mucosa of human, of which understaning might provide insihgts for prevention, diagnosis, and treatment of H. pylori infection.
Bacterial Infections
;
Bias (Epidemiology)
;
Colon
;
Diagnosis
;
Gastric Juice
;
Gastric Mucosa
;
Gastritis
;
Helicobacter pylori*
;
Helicobacter*
;
Humans
;
Peptic Ulcer
;
Stomach
;
Stomach Neoplasms
3.The Changes in Prevalence and the Related Factors of Helicobacter pylori Infection in Korean Health Check-up Subjects during 8 Years.
Mi Young DO ; Yong Chan LEE ; Chang Hwan CHOI ; Sang Joong KIM ; Chang Sik MUN ; Hong Ju MOON ; Hyun Woong LEE ; Hyung Chul OH ; Hyung Joon KIM ; Jeong Wook KIM ; Jae Hyuk DO ; Jae Gyu KIM ; Sae Kyung CHANG
The Korean Journal of Gastroenterology 2009;53(2):76-83
BACKGROUND/AIMS: The aim of this study was to evaluate the changes in prevalence and the related factors of Helicobacter pylori (H. pylori) infection in Korean health check-up subjects during the period of 8 years. METHODS: Among 89,231 subjects who visited the Health Promotion Centers of Severance hospital or Chung-Ang University hospital from Jan. 1998 through Dec. 2005, a total of 10,553 subjects who received esophagogastroduodenoscopy (EGD) and H. pylori test were enrolled. H. pylori infection was assessed by histologic examination. Changes of the prevalence of H. pylori infection during 8 years, and infection-related factors such as demographic characteristics, body mass index, ABO blood types, endoscopic findings (presence of peptic ulcer diseases), educational level, economic status, smoking habits, and alcohol intake in year 2005 were analyzed. RESULTS: The mean age of 10,553 subjects (7,329 men, 3,224 women) was 49.7+/-10.4 years (range from 17 to 92 years). The prevalence of H. pylori infection at the first, second, third, fourth, fifth, sixth, seventh, and eighth year were 64.7%, 58.1%, 54.2%, 50.4%, 48.9%, 49.5%, 39.6%, and 40.0%, respectively, and these serial decreases in prevalence over 8 years were statistically significant (p<0.001). Regardless of sex, age or EGD findings, the prevalence of H. pylori infection was significantly decreased. In the analysis of the H. pylori infection-related factors in 2005, only age and EGD findings (peptic ulcer diseases) were significant factors. CONCLUSIONS: The prevalence of H. pylori infection was significantly decreased during 8-year period in Korean health check-up subjects. Age and peptic ulcer diseases were the two significant factors related to H. pylori infection in Korea.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Demography
;
Endoscopy, Digestive System
;
Female
;
Helicobacter Infections/complications/diagnosis/*epidemiology
;
*Helicobacter pylori
;
Humans
;
Korea
;
Male
;
Middle Aged
;
Peptic Ulcer/etiology
;
Prevalence
;
Retrospective Studies
4.Association between Dyspepsia and Upper Endoscopic Findings.
Hye Kyung JUNG ; Seong Eun KIM ; Ki Nam SHIM ; Sung Ae JUNG
The Korean Journal of Gastroenterology 2012;59(4):275-281
BACKGROUND/AIMS: We aimed to estimate the proportion of significant endoscopic findings and their association with dyspeptic symptoms and to evaluate the predictors for significant endoscopic findings. METHODS: Total of 3,872 subjects (58.3% men, mean age 43.6+/-9.3 years) who had undergone endoscopy were enrolled at the health promotion center. Each subject completed validated questionnaires, including data on gastrointestinal symptoms, socio-demographic history and medical history. Significant endoscopic findings were included peptic ulcer disease, reflux esophagitis, gastric cancer, Barrett's esophagus and gastro-duodenal erosions. Multiple logistic regression models were used to assess the predictors for significant endoscopic findings. RESULTS: The proportion of significant endoscopic findings was 39.1%. There was no significant difference of endoscopic findings between the dyspepsia and asymptomatic group (41.0% vs. 37.4%, p>0.05). There was no difference of the incidence of reflux esophagitis or peptic ulcer between subjects with and without dyspepsia. Peptic ulcer was more frequently present in subjects with reflux symptoms than asymptomatic subjects (12.3% vs. 9.0%, p=0.03). Male gender (odds ratio [OR], 3.91; 95% confidence interval [CI], 3.18-4.81) increased the risk for having endoscopic abnormality and having symptoms of functional dyspepsia according to Rome III criteria (OR, 0.75; 95% CI, 0.57-0.97) significantly decreased this risk. CONCLUSIONS: About 40% of subjects with dyspepsia had abnormal endoscopic findings, and the dyspepsia symptoms may not predict the significant endoscopic findings. Diagnostic criteria of functional dyspepsia by Rome III may be useful to predict not having significant upper endoscopic findings.
Adult
;
Aged
;
Aged, 80 and over
;
Dyspepsia/*diagnosis
;
Female
;
Gastroesophageal Reflux/diagnosis/epidemiology
;
*Gastroscopy
;
Humans
;
Logistic Models
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Peptic Ulcer/diagnosis/epidemiology
;
Postprandial Period
;
Predictive Value of Tests
;
Questionnaires
;
Severity of Illness Index
;
Sex Factors
;
Upper Gastrointestinal Tract/pathology
;
Young Adult
5.Clinical Characteristics of Patients Diagnosed as Peptic Ulcer Disease in the Third Referral Center in 2007.
Jin Joo KIM ; Nayoung KIM ; Hyun Kyung PARK ; Hyun Jin JO ; Cheol Min SHIN ; Sang Hyup LEE ; Young Soo PARK ; Jin Hyeok HWANG ; Jin Wook KIM ; Sook Hyang JEONG ; Dong Ho LEE ; Jung Mogg KIM ; Ji Hyun LEE ; Hyun Chae JUNG ; In Sung SONG
The Korean Journal of Gastroenterology 2012;59(5):338-346
BACKGROUND/AIMS: In spite of the improvement of medical treatment for the peptic ulcer disease (PUD), PUD is still one of the common upper gastrointestinal diseases. The purpose of this study was to evaluate the risk factors and general characteristics of Korean patients diagnosed as PUD at a single third referral center. METHODS: A total of 310 patients, diagnosed as PUD through endoscopy during one year of 2007 at Seoul National University Bundang Hospital were, retrospectively, evaluated regarding age, gender, Helicobacter pylori (H. pylori) positivity, clinical manifestations, comorbidities and medications. In addition, PUD was analyzed in the aspect of ulcer location, type of visit, gastrointestinal bleeding, and age. RESULTS: The mean age was 61.5 years old (48.1% over 65) and 208 (66.7%) patients were men. The rate of H. pylori infection was 47.8%, and any ulcerogenic medication history such as antiplatelet agents and NSAIDs was found to be 21.0% (65 patients). The rate of idiopathic peptic ulcer without evidence of H. pylori and NSAIDs was found to be 40.6% (126 patients). Among 310 PUD patients, bleeding symptoms such as melena, hematemesis and hematochezia occurred in 110 patients (35.5%). CONCLUSIONS: PUD was more prevalent in the elderly patients and frequently associated with bleeding. Substantial proportion of PUD patients had neither H. pylori infection nor history of ulcerogenic medications, suggesting of increasing prevalence of idiopathic PUD.
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
;
Female
;
Gastrointestinal Hemorrhage
;
Gastroscopy
;
Helicobacter Infections/complications/diagnosis
;
Helicobacter pylori
;
Hematemesis
;
Humans
;
Male
;
Melena
;
Middle Aged
;
Peptic Ulcer/*diagnosis/drug therapy/epidemiology
;
Platelet Aggregation Inhibitors/therapeutic use
;
Prevalence
;
Referral and Consultation
;
Retrospective Studies
;
Risk Factors
;
Sex Factors
6.Clinical Impact of Dual Antiplatelet Therapy on Peptic Ulcer Disease.
Dae Geon AHN ; Beom Jin KIM ; Jeong Wook KIM ; Jae Gyu KIM
The Korean Journal of Gastroenterology 2014;64(2):81-86
BACKGROUND/AIMS: Increased incidence of coronary artery disease has led to the increased use of dual antiplatelet therapy composed of aspirin and clopidogrel. We investigated the incidence of gastrointestinal complications in patients who received single or dual antiplatelet therapy and analyzed their clinical characteristics in order to predict the prognostic factors. METHODS: Between January 2009 and December 2011, we retrospectively reviewed the medical records of patients who underwent coronary angiography at Chung-Ang University Hospital (Seoul, Korea). One hundred and ninety-four patients were classified into two groups: aspirin alone group and dual antiplatelet group. Clinical characteristics, past medical history, and presence of peptic ulcer were analyzed. RESULTS: During the follow-up period, 11 patients had duodenal ulcer; the event rate was 2.02% in the aspirin alone group and 9.47% in the dual antiplatelet group (hazard ratio [HR] 5.24, 95% CI 1.03-26.55, p<0.05). There was no significant difference in the rate of significant upper gastrointestinal bleeding: 0% vs. 4.2% (p=0.78). In patients who received proton pump inhibitor (PPI), 24 patients had gastric ulcer; the event rate was significantly different between the two groups: 4.87% vs. 22.98% (HR 3.40, 95% CI 1.02-11.27, p<0.05). CONCLUSIONS: Dual antiplatelet groups had a higher incidence of duodenal ulcers without significant bleeding compared with the aspirin alone group. In patients who received PPI, the dual antiplatelet therapy group had a higher incidence of gastric ulcers without significant bleeding compared with the aspirin alone group. Therefore, physicians must pay attention to high risk groups who receive dual antiplatelet therapy and aggressive diagnostic endoscopy should also be considered.
Aged
;
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use/toxicity
;
Aspirin/*therapeutic use/toxicity
;
Coronary Angiography
;
Coronary Artery Disease/*prevention & control
;
Drug Therapy, Combination
;
Female
;
Gastrointestinal Hemorrhage/chemically induced/prevention & control
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Peptic Ulcer/*diagnosis/epidemiology/etiology
;
Platelet Aggregation Inhibitors/*therapeutic use/toxicity
;
Proportional Hazards Models
;
Proton Pump Inhibitors/therapeutic use
;
Retrospective Studies
;
Risk Factors
;
Ticlopidine/*analogs & derivatives/therapeutic use/toxicity